<DOC>
	<DOCNO>NCT02360683</DOCNO>
	<brief_summary>This study identify preoperative predictor response subthalamic stimulation 1 year , 3 year 5 year term quality life , broad prospective multicenter study French standardize collection clinical data , image genetic . The investigator want identify factor predict improvement quality life one year correspond decrease PDQ39 score least 20 % . They believe improvement would less likely become zero 3 5 year question indication subthalamic stimulation ( risks cost ) . This part process `` personalization '' therapeutic care interest subthalamic stimulation . It therapeutic option could dangerous patient selection optimal , expensive , benefit large enough reduce number medication hospitalization medium term . In addition , quantify improvement quality life long term harmonize national assessment .</brief_summary>
	<brief_title>Predictive Factors Subthalamic Stimulation Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients receive pre therapeutic assessment therapeutic monitoring one year , 3 year 5 year part regular monitoring subthalamic stimulation Bilateral STN stimulation consider Patient able provide free informed consent Patient insurance coverage Atypical Parkinson 's disease meet criterion stuff . MP 5 year Severe cognitive impairment dementia ( Score Moca &lt; 24 DSMIV criterion ) Parkinson 's Psychosis Reply L dopa &lt; 30 % Against indication surgery Severe brain atrophy abnormal MRI The presence another serious condition terminal life shortterm prognosis ( malignancy ) indication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Subthalamic neurostimulation</keyword>
</DOC>